Translating Biomarker Discovery: From Bench to Bedside in Dry Eye Disease
International Journal of Molecular Sciences · 03.09.2025 · 26 (17) · 8556
DOI: 10.3390/ijms26178556 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.09.2025. Verfasst von Jeremy Jones und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pittsburgh Research Institute, Sewickley, PA 15143, USA. Hauptthemen laut MEDLINE: Biomarkers, Dry Eye Syndromes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Dry Eye Disease (DED) is a complex, multifaceted ocular disease characterized by tear film instability and inflammation. It can sometimes be elusive to identify the type of DED in patients, given the overlapping symptoms with other conditions like allergies and the multitude of stimuli that might trigger DED onset. There is also difficulty due to limitations on the diagnostic testing available to clinicians, as poor reliability and a lack of standardization plague accurate diagnoses. Identified biomarkers can help identify DED pathophysiology and category, and these include molecular biomarkers like matrix metalloproteinase-9 (MMP-9), cytokines, lactotransferrin, and lacritin, as well as functional biomarkers such as tear osmolarity. Diagnostic tools, such as the InflammaDry and I-Pen Tear Osmolarity System, also now allow for point-of-care measurement of select biomarkers, including MMP-9 and osmolarity. Nonetheless, there remains a critical need for additional, reliable, and accurate diagnostic devices to better aid in the diagnosis and management of DED. This review uniquely combines a review on the current understanding of various biomarkers with an overview of the emerging technologies available to healthcare providers, aiding in better-informed diagnosis and treatment of DED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pittsburgh Research Institute, Sewickley, PA 15143, USA.
- Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15260, USA.
- Department of Biomedical Engineering, College of Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
- Southwestern PA Eye Center, Corneal Services, Washington, PA 15301, USA.
- Eger Eye Group, Optometry, Coraopolis, PA 15108, USA.
- University of Pittsburgh Medical Center, Corneal Services, Pittsburgh, PA 15260, USA.
ORCID-Profile: Kyla Frenia, Julia Gelman, Levin Ma
Zitieren
APA
Jones, J., Frenia, K., Gelman, J., Beatty, M., Zhou, M., Ma, L., Pieramici, S., Eger, N., Dhaliwal, D., Labriola, L. T., & Xiao, K. (2025). Translating Biomarker Discovery: From Bench to Bedside in Dry Eye Disease. International Journal of Molecular Sciences, 26(17), 8556. https://doi.org/10.3390/ijms26178556
Vancouver
Jones J, Frenia K, Gelman J, Beatty M, Zhou M, Ma L, et al. Translating Biomarker Discovery: From Bench to Bedside in Dry Eye Disease. International Journal of Molecular Sciences. 2025;26(17):8556. doi:10.3390/ijms26178556
BibTeX
@article{Jones2025,
author = {Jones, Jeremy and Frenia, Kyla and Gelman, Julia and Beatty, Maria and Zhou, Melody and Ma, Levin and Pieramici, Sean and Eger, Noah and Dhaliwal, Deepinder and Labriola, Leanne T and Xiao, Kunhong},
title = {Translating Biomarker Discovery: From Bench to Bedside in Dry Eye Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {17},
pages = {8556},
doi = {10.3390/ijms26178556}
}
EUVIMED